The mutation spectrum revealed by paired genome sequences from a lung cancer patient

@article{Lee2010TheMS,
  title={The mutation spectrum revealed by paired genome sequences from a lung cancer patient},
  author={William Lee and Zhaoshi Jiang and Jinfeng Liu and Peter M. Haverty and Yinghui Guan and Jeremy Stinson and Peng Yue and Yan Zhang and Krishna Prasad Pant and Deepali Bhatt and Connie Ha and Stephanie Johnson and Michael I. Kennemer and Sankar Mohan and Igor Nazarenko and Colin K. Watanabe and Andrew B. Sparks and David S. Shames and Robert Gentleman and Frederic j. de Sauvage and Howard M. Stern and Ajay Pandita and Dennis Ballinger and R. Drmanac and Zora Modru{\vs}an and Somasekar Seshagiri and Zemin Zhang},
  journal={Nature},
  year={2010},
  volume={465},
  pages={473-477}
}
Lung cancer is the leading cause of cancer-related mortality worldwide, with non-small-cell lung carcinomas in smokers being the predominant form of the disease. Although previous studies have identified important common somatic mutations in lung cancers, they have primarily focused on a limited set of genes and have thus provided a constrained view of the mutational spectrum. Recent cancer sequencing efforts have used next-generation sequencing technologies to provide a genome-wide view of… 

Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing.

Several highly mutated genes identified in the study are promising druggable targets in cancer therapy including ALK, CTNNA3, DCC, MLL3, PCDHIIX, Pik3C2B, PIK3CG and ROCK2.

An Integrated Inspection of the Somatic Mutations in a Lung Squamous Cell Carcinoma Using Next-Generation Sequencing

The results show that LUDLU-1 lacks the mutational signature that has been previously associated with tobacco exposure in other lung cancer subtypes, and suggests that DNA-repair efficiency is adversely affected, and shows how integrated analyses of high-throughput data can generate hypotheses to be tested in the lab.

Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events

Deep whole-genome sequencing and transcriptome sequencing on 19 lung cancer cell lines and three lung tumor/normal pairs show that cell line models exhibit similar mutation spectra to human tumor samples, and demonstrate that cancer-specific alternative splicing is a widespread phenomenon that has potential utility as therapeutic biomarkers.

Identification of genome variations in patients with lung adenocarcinoma using whole genome re-sequencing

In conclusion, the results of the present study generated an output of the genome alterations in lung adenocarcinoma, and provided a foundation for further investigation of the pathogenesis of lungAdenocARCinoma.

New Lung Cancer Panel for High-Throughput Targeted Resequencing

The results demonstrated the feasibility of high-throughput mutation profiling with lung adenocarcinoma samples, and the profiling method can be used as a robust and effective protocol for somatic variant screening.

Exome sequencing identifies frequent mutation of MLL2 in non–small cell lung carcinoma from Chinese patients

The landscape of somatic mutations in Chinese NSCLC is defined and the role of MLL2 mutation in the pathogenesis of the disease is supported, which was commonly observed in tumor tissues as compared with paired adjacent non-tumors regardless of mutation status.

Identification of somatic alterations in stage I lung adenocarcinomas by next‐generation sequencing

Cell adhesion was the most enriched biological process in gene set analysis using the DAVID database and copy number amplification at 12q15, which includes MDM2, was identified as a recurrent somatic alteration in 4 of 10 tumors.

Molecular biology of lung cancer.

Lung cancers are characterised by abundant genetic diversity with relatively few recurrent mutations occurring at high frequency. However, the genetic alterations often affect a common group of

The transcriptional consequences of somatic amplifications, deletions, and rearrangements in a human lung squamous cell carcinoma.

This work characterize a lung SCC genome to unprecedented detail and integrates the findings with the concurrently characterized transcriptome to ascertain how somatic structural changes affected gene expression within the cell in ways that could confer a pathogenic phenotype.
...

References

SHOWING 1-10 OF 32 REFERENCES

Characterizing the cancer genome in lung adenocarcinoma

A large-scale project to characterize copy-number alterations in primary lung adenocarcinomas using dense single nucleotide polymorphism arrays identifies NKX2-1 (NK2 homeobox 1, also called TITF1), which lies in the minimal 14q13.3 amplification interval and encodes a lineage-specific transcription factor, as a novel candidate proto-oncogene involved in a significant fraction of lung carcinomas.

Somatic mutations affect key pathways in lung adenocarcinoma

Somatic mutations in primary lung adenocarcinoma for several tumour suppressor genes involved in other cancers and for sequence changes in PTPRD as well as the frequently deleted gene LRP1B are found.

A comprehensive catalogue of somatic mutations from a human cancer genome

The genomes of a malignant melanoma and a lymphoblastoid cell line from the same person are sequenced, providing the first comprehensive catalogue of somatic mutations from an individual cancer.

A small-cell lung cancer genome with complex signatures of tobacco exposure

Using massively parallel sequencing technology, a small-cell lung cancer cell line, NCI-H209, is sequenced to explore the mutational burden associated with tobacco smoking and identifies a tandem duplication that duplicates exons 3–8 of CHD7 in frame, and another two lines carrying PVT1–CHD7 fusion genes, indicating that ChD7 may be recurrently rearranged in this disease.

Somatic mutations of the protein kinase gene family in human lung cancer.

The results suggest that several mutated protein kinases may be contributing to lung cancer development, but that mutations in each one are infrequent.

DNA sequencing of a cytogenetically normal acute myeloid leukemia genome

This study establishes whole-genome sequencing as an unbiased method for discovering cancer-initiating mutations in previously unidentified genes that may respond to targeted therapies.

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

The data show that single nucleotide mutational heterogeneity can be a property of low or intermediate grade primary breast cancers and that significant evolution can occur with disease progression, and two new RNA-editing events that recode the amino acid sequence of SRP9 and COG3 are revealed.

Patterns of somatic mutation in human cancer genomes

More than 1,000 somatic mutations found in 274 megabases of DNA corresponding to the coding exons of 518 protein kinase genes in 210 diverse human cancers reveal the evolutionary diversity of cancers and implicates a larger repertoire of cancer genes than previously anticipated.

Recurring mutations found by sequencing an acute myeloid leukemia genome.

By comparing the sequences of tumor and skin genomes of a patient with AML-M1, recurring mutations that may be relevant for pathogenesis are identified.

Novel patterns of genome rearrangement and their association with survival in breast cancer.

Analysis of a selected subset of clinical material suggests that a simple genomic calculation, based on the number and proximity of genomic alterations, correlates with life-table estimates of the probability of overall survival in patients with primary breast cancer.